Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Dragonfly Energy Holdings Corp., a leading US lithium battery technology company known for its Battle Born Batteries brand, will release its second quarter 2026 financial and operational results after market close on August 6, 2026. A conference call and live webcast will follow for investors and other interested parties. The company continues to f…
Leonardo DRS delivered robust Q2 2026 results with 10% revenue growth and a 59% increase in net earnings year-over-year. The company increased its 2026 adjusted EBITDA and adjusted diluted EPS guidance, supported by a record funded backlog of $5.1 billion. The $450 million acquisition of Raft enhances its AI, data fusion, and mission software capab…
SIGA Technologies, a commercial-stage pharmaceutical company specializing in infectious disease treatments, has scheduled a webcast and conference call for August 6, 2026, to discuss its second-quarter financial results and provide a business update. The call will be led by CEO Diem Nguyen and CFO Daniel Luckshire, and is accessible via webcast and…
Wave Life Sciences reported its Q2 2026 financial results, highlighting progress in its RNA-based drug pipeline including dosing initiation in Phase 2a obesity trial (WVE-007), a scheduled FDA meeting for accelerated approval pathway for its AATD therapy (WVE-006), and upcoming clinical trial application for its liver disease candidate (WVE-008). T…
Saia, Inc. announced its second quarter 2026 financial results, highlighting a 17.1% increase in revenue to $956.5 million, a 26.0% increase in operating income to $125.2 million, and diluted earnings per share of $3.51, up from $2.67 in Q2 2025. The company saw growth in LTL shipments and tonnage, maintained a low claims ratio, improved operating …
DT Midstream, Inc. announced strong financial results for Q2 2026 including a net income and operating earnings of $112 million, or $1.09 per diluted share. Adjusted EBITDA reached $305 million for the quarter. The company declared a $0.88 per share dividend and reaffirmed its 2026 Adjusted EBITDA guidance of $1.155 to $1.225 billion and 2027 outlo…
Laureate Education, Inc. announced robust financial results for Q2 2026, including 17% revenue growth to $615.9 million and a 40% increase in net income compared to Q2 2025. The company also reported a 10% increase in new enrollments and a 6% increase in total enrollments for the first half of 2026. Due to strong operating momentum and favorable cu…
FTI Consulting reported record second quarter 2026 revenues of $993.5 million, a 5.3% increase year-over-year driven by growth in Corporate Finance, Technology, and Forensic and Litigation Consulting segments. Despite higher revenues, net income decreased primarily due to increased costs, and GAAP EPS fell to $1.99 from $2.13 last year. Adjusted EP…
InflaRx N.V., a Nasdaq-listed biopharmaceutical company specializing in anti-inflammatory therapeutics targeting the complement system, will report its second quarter 2026 financial and operating results on August 6, 2026, before market open. The company focuses on developing treatments like izicopan and vilobelimab for inflammatory and renal disea…
Tvardi Therapeutics has selected ulcerative colitis (UC) as the first clinical indication for its oral STAT3 inhibitor, TTI-109, after positive results from a Phase 1 healthy volunteer study demonstrating immunomodulatory effects on immune cell populations implicated in UC pathogenesis. The company plans to initiate a moderate-to-severe UC clinical…
Mobilicom Limited announced a significant design win with an Israeli defense technology company developing AI-enabled autonomous weapon systems. The company has delivered integrated software and hardware, including cybersecurity software (OS3), electronic warfare resistance (ICE), secure datalinks (SkyHopper), and ground control stations. This desi…
Palvella Therapeutics announced that its Chief Scientific Officer, Dr. Jeffrey Martini, has been invited to provide public comments at an upcoming FDA public workshop focused on drug repurposing. The meeting will address selection criteria and regulatory considerations for advancing repurposed therapies, particularly targeting rare and chronic dise…
Huntington Ingalls Industries jumped sharply in pre-market trading after reporting second-quarter 2026 results that topped consensus and announcing its Newport News Shipbuilding unit was part of a team awarded roughly $76.6 billion in U.S. Navy contract modifications. The company also declared a quarterly cash dividend, while strong results from de…
The Bank of England left its policy rate unchanged at 3.75% following a 6-3 split on the Monetary Policy Committee. In accompanying analysis it published three scenarios - central, milder and adverse - that outline alternative paths for inflation, output, and energy prices through 2029. Markets are pricing a high probability of two rate hikes by Q3…
Alterity Therapeutics announced an FDA End-of-Phase 2 meeting outcome confirming a clear regulatory pathway for its drug ATH434 targeting Multiple System Atrophy (MSA). The FDA accepted a single pivotal Phase 3 trial plus confirmatory evidence to support approval, with Phase 3 trial initiation planned by the end of 2026. The company also reported c…
Hyatt Hotels shares dropped sharply in pre-market trading after the company published its second-quarter 2026 results before the opening bell. The report failed to meet elevated consensus estimates for adjusted EPS and revenue, prompting a nearly 5% pre-open decline as investors reassessed the pace of the company's fee-driven recovery amid a backdr…
Sirius XM shares fell sharply in pre-market trading after the company released its second-quarter 2026 operating and financial results. The stock dropped 5.7% to $30.75, reversing part of a year-to-date rally that had driven the price to a 52-week high in the prior session. Analyst price targets below the pre-earnings level and ongoing subscriber l…
Capricor Therapeutics shares tumbled sharply in pre-market trade after the FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee voted 9-3 that the Phase 3 HOPE-3 trial did not provide substantial evidence that deramiocel is effective for treating cardiomyopathy in Duchenne muscular dystrophy. The advisory panel meeting featured a dispute o…
Check Point Software shares tumbled in pre-market trading after the company reported Q2 2026 results that fell short of Street revenue estimates and included a reduction to full-year revenue guidance. The miss came amid recent analyst downgrades and insider selling, and overshadowed a product announcement for an AI-focused network firewall. The dro…
Norwegian Cruise Line Holdings (NCLH) plunged in pre-market trading after reporting second-quarter 2026 results that combined an earnings beat with a revenue shortfall and a material cut to full-year adjusted EPS guidance. Investors focused on guidance of about $1.50 for 2026, below the Street estimate of $1.67, while management flagged continued d…
Crocs Inc. shares tumbled in pre-market trading after the company posted its Q2 2026 results and reiterated guidance that disappointed the market. The decline centered on continued weakness at the HEYDUDE brand, tariff-driven margin headwinds and forward guidance that left investors unconvinced, triggering a sell-the-news reaction after a strong ru…
Cinemark Holdings reported second-quarter 2026 results that surpassed consensus on both earnings and revenue, driven by a record-setting domestic summer box office. The company posted $1.19 per share in earnings on $1.09 billion of revenue, beating estimates of about $1.02 and $1.03 billion, respectively. The news, coupled with an analyst price-tar…
Meta's core advertising business remains the profit engine that can finance aggressive AI and Reality Labs investments. The stock is down from its highs, trading at a reasonable multiple for a cash-generative ad giant with optionality in AI. This trade idea outlines a long-term (180 trading days) buy with clear entry, target, and stop levels while …
Brazilian President Luiz Inacio Lula da Silva confirmed his government denied visas to two officials from the United States, saying they were being sent to interfere in Brazil’s upcoming general election in October. Brazilian authorities have said the officials planned to cast doubt on the integrity of the electoral system. A U.S. State Department …
The Bank of England held its key interest rate at 3.75% on Thursday while warning that higher energy prices pose an upside risk to inflation and that policy may need to tighten further to ensure inflation returns to 2%. Three members dissented, preferring a 25 basis-point rise to 4%, reflecting debate over how persistent energy costs will feed thro…
